QuaCell was awarded the Specialized and Sophisticated Enterprises for 2022 in Guangdong Province

April 23, 2023

QuaCell Was Named to Top 100 Life Sciences Services Corporate Brands

December 10, 2022

QuaCell Delivered Sample Production of Agonistic Antibody Program Clinical Phase I and Signed Agreement on Strategic Cooperation with Constimulus

December 10, 2022

QuaCell's Initiation of Suzhou Manufacturing Site

December 10, 2022

QuaCell has been Named to Biotechnology Innovation 50 List

November 1, 2022

Drug Master Files (DMF) are available for the QuaCell® CHO cell culture medium series, facilitating antibody drug projects filing

October 27, 2022